France has confirmed the world's first documented human infection with the Shamonda virus, a disease previously detected only in animals. The patient, who had a severely weakened immune system and was receiving treatment for a serious illness in Lyon, died in early October 2026. French health authorities announced the case on October 22, emphasizing that no health risk to the general population has been identified.

First Human Shamonda Virus Case in France

The French health and agriculture ministries confirmed that the patient was receiving treatment at Hospices Civils de Lyon. The infection represents the first documented detection of Shamonda virus in humans, despite decades of circulation among livestock in Africa and Asia.

Officials described the incident as exceptional because the patient was severely immunocompromised. They have not established whether the virus caused or contributed to the patient's death.

Shamonda Virus Symptoms and Transmission

Shamonda belongs to the Orthobunyavirus group and primarily spreads among animals through bites from tiny insects called Culicoides midges.

Investigators suspect the patient contracted the infection through a midge bite in eastern France, where the virus circulated among livestock during spring and summer 2026.

Because this is the first identified human infection, doctors do not yet know the full range of symptoms or how commonly healthy individuals might become infected.

Shamonda Virus Outbreak in European Livestock

Scientists first identified Shamonda virus in Nigeria during the mid-1960s. It was subsequently detected in cattle across parts of Africa and Japan.

The virus appeared in European livestock for the first time during summer 2026. Infected cattle may develop fever, diarrhoea, lethargy and reduced milk production.

European surveillance has also identified infections in other farm animals, including smaller ruminants and horses.

Shamonda Virus Public Health Risk Assessment

French authorities have stressed that the isolated human infection does not currently indicate a wider public health threat.

The European Centre for Disease Prevention and Control is monitoring developments and working with French officials to assess the implications of the case.

Health agencies are also examining whether additional testing or surveillance measures are necessary as knowledge of the virus develops.

Investigation Into Shamonda Virus Patient Death

Preliminary findings suggest that neurological complications experienced by the patient before death were likely associated with the infection.

However, clinical, laboratory and epidemiological investigations are continuing to clarify the circumstances and the virus's possible contribution to the fatal outcome.

French officials have notified the World Health Organization and European health authorities. Their investigation combines human, animal and environmental health expertise to better understand this previously undocumented human infection.